|
|
|
 |
|
 |
IPO and financial highlights
 Kamada was first offered in August 2005 at the Tel Aviv Stock Exchange (TASE: KMDA).
Up to December 2007, the company has raised more than $ 139 million in shares and options since it has been issued in 2005, and its value has increased by more than 500%
During 2007, the company's manufacturing plant was upgraded to FDA/EMEA standards for an estimated cost of $ 5.5 million.
Since the beginning of 2007, the company stock price has increased by more than 70%.
In addition, loans of interested parties in the company, and private investors lead by Leon Recanati's investment company were converted into capital totaling NIS 20 million
In August 2006, the company completed fund raising of an additional NIS 48 million through traded warrants exercise (series II) in the TASE
Up to December 2007, the company has raised a total of NIS 41 million, through the converting of traded options (series I), by interested parties and others.
| TYPE |
NAME |
SYMBOL |
![]() |
![]() |
![]() |
| Share |
KAMADA |
KMDA |
![]() |
|
|
|
|
|
More
|
